Artesunate for Injection / Amivas - LARVOL DELTA

Study Evaluating the Efficacy and Safety of Artesunate (clinicaltrials.gov) - P2 | N=90 | Recruiting | Sponsor: Amivas Inc. | Not yet recruiting ➔ Recruiting | Initiation date: May 2025 ➔ Aug 2025

Enrollment open • Trial initiation date • Cytomegalovirus Infection • Infectious Disease • Solid Organ Transplantation • Transplantation

Study Evaluating the Efficacy and Safety of Artesunate (clinicaltrials.gov) - P2 | N=90 | Not yet recruiting | Sponsor: Amivas (US), LLC

New P2 trial • Cytomegalovirus Infection • Infectious Disease • Solid Organ Transplantation • Transplantation

Evaluation of Artesunate in Infants Being Treated for Severe Malaria (clinicaltrials.gov) - P=N/A | N=15 | Recruiting | Sponsor: Amivas (US), LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Malaria

Evaluation of Artesunate in Infants Being Treated for Severe Malaria (clinicaltrials.gov) - P=N/A | N=15 | Not yet recruiting | Sponsor: Amivas (US), LLC

New trial • Infectious Disease • Malaria